Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 22, 2021
Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational Toxicity
Wenyue Hu, Daniel Lettiere, Susanna Tse, et al.
The AAPS Journal
|
May 21, 2016
Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin
Alison M Betts, Nahor Haddish-Berhane, John Tolsma, et al.
Advances in Therapy
|
September 3, 2016
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade<sup>®</sup> (Infliximab)
Mazin Derzi, Theodore R Johnson, Ahmed M Shoieb, et al.
Journal of Medicinal Chemistry
|
May 14, 2010
Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery
Lorna H Mitchell, Theodore R Johnson, Guang Wei Lu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 19, 2014
Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects
Theodore R Johnson, Weiwei Tan, Lance Goulet, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production
Lain-Yen Hu, Huangshu John Lei, Daniel Du, et al.
Nature Cancer
|
June 21, 2022
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
Aya Shiba-Ishii, Ted W Johnson, Ibiayi Dagogo-Jack, et al.
Journal of Medicinal Chemistry
|
October 17, 2008
Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications
Jie Jack Li, Donna M Iula, Maria N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
Lain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 22, 2021
Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational Toxicity
Wenyue Hu, Daniel Lettiere, Susanna Tse, et al.
The AAPS Journal
|
May 21, 2016
Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin
Alison M Betts, Nahor Haddish-Berhane, John Tolsma, et al.
Advances in Therapy
|
September 3, 2016
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade<sup>®</sup> (Infliximab)
Mazin Derzi, Theodore R Johnson, Ahmed M Shoieb, et al.
Journal of Medicinal Chemistry
|
May 14, 2010
Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery
Lorna H Mitchell, Theodore R Johnson, Guang Wei Lu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
July 19, 2014
Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects
Theodore R Johnson, Weiwei Tan, Lance Goulet, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production
Lain-Yen Hu, Huangshu John Lei, Daniel Du, et al.
Nature Cancer
|
June 21, 2022
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
Aya Shiba-Ishii, Ted W Johnson, Ibiayi Dagogo-Jack, et al.
Journal of Medicinal Chemistry
|
October 17, 2008
Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications
Jie Jack Li, Donna M Iula, Maria N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
Lain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Page
of 2